{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:30:54Z","timestamp":1789212654923,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.jpeds.2005.06.001","type":"journal-article","created":{"date-parts":[[2005,11,14]],"date-time":"2005-11-14T12:01:40Z","timestamp":1131969700000},"page":"603-608","source":"Crossref","is-referenced-by-count":73,"title":["Potential Costs and Benefits of Newborn Screening for Severe Combined Immunodeficiency"],"prefix":"10.1016","volume":"147","author":[{"given":"Sean A.","family":"McGhee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Richard","family":"Stiehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.B.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2005.06.001_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.immunol.22.012703.104614","article-title":"Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution","volume":"22","author":"Buckley","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jpeds.2005.06.001_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99","volume":"361","author":"Antoine","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2005.06.001_bib3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199902183400703","article-title":"Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency","volume":"340","author":"Buckley","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2005.06.001_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood.V99.3.872","article-title":"Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival","volume":"99","author":"Myers","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2005.06.001_bib5","article-title":"Newborn Screening: Toward a Uniform Screening Panel and System","volume":"70","author":"Health Resources and Services Administration, Maternal and Child Health Bureau","year":"2005","journal-title":"Federal Register"},{"key":"10.1016\/j.jpeds.2005.06.001_bib6","first-page":"1","article-title":"Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders","volume":"53","author":"Lindegren","year":"2004","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jpeds.2005.06.001_bib7","first-page":"473","article-title":"How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations","volume":"146","author":"Laupacis","year":"1992","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jpeds.2005.06.001_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/0272989X0002000310","article-title":"Willingness to pay for a quality-adjusted life year: in search of a standard","volume":"20","author":"Hirth","year":"2000","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jpeds.2005.06.001_bib9","series-title":"Cost-effectiveness in health and medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.jpeds.2005.06.001_bib10","unstructured":"US Department of Labor, Bureau of Labor Statistics [homepage on the Internet]. Washington, D.C.; 2003 [cited 2003 Aug] Consumer Price Indexes. Available from: http:\/\/www.bls.gov\/cpi\/. Accessed Jan 8, 2005."},{"key":"10.1016\/j.jpeds.2005.06.001_bib11","first-page":"479","article-title":"The spectrum of primary immunodeficiency disorders in Australia","volume":"8","author":"Baumgart","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jpeds.2005.06.001_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1023\/A:1026416017763","article-title":"Primary immunodeficiency diseases in Norway","volume":"20","author":"Stray-Pedersen","year":"2000","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jpeds.2005.06.001_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF00916891","article-title":"Primary immunodeficiency disorders in Sweden: cases among children","volume":"2","author":"Fasth","year":"1982","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jpeds.2005.06.001_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/A:1020660416865","article-title":"Primary immunodeficiency in Iran: first report of the National Registry of PID in Children and Adults","volume":"22","author":"Aghamohammadi","year":"2002","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jpeds.2005.06.001_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1027382916924","article-title":"Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults","volume":"17","author":"Matamoros","year":"1997","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jpeds.2005.06.001_bib16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF00916954","article-title":"Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children","volume":"8","author":"Ryser","year":"1988","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jpeds.2005.06.001_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.GIM.0000105752.80592.A3","article-title":"Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS and ADA and severe combined immunodeficiency: HuGE review","volume":"6","author":"Kalman","year":"2004","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2005.06.001_bib18","unstructured":"Fields J. Children's living arrangements and characteristics: March 2002. U.S. Census Bureau, Washington, DC; 2003."},{"key":"10.1016\/j.jpeds.2005.06.001_bib19","unstructured":"Agency for Healthcare Research and Quality [homepage on the Internet]. Rockville, MD; 2003 [cited 2003 Aug] Healthcare Cost and Utilization Project Kids' Inpatient Database. Available from: http:\/\/www.hcup-us.ahrq.gov\/kidoverview.jsp\/. Accessed Jan 25, 2005."},{"key":"10.1016\/j.jpeds.2005.06.001_bib20","series-title":"Red Book: Pharmacy's fundamental reference","year":"2004"},{"key":"10.1016\/j.jpeds.2005.06.001_bib21","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.1997.03550220224028","article-title":"Outcome analysis and cost assessment in immunologic disorders","volume":"278","author":"Stadtmauer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2005.06.001_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-125-7-199610010-00002","article-title":"Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia","volume":"125","author":"Kattan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpeds.2005.06.001_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM199107113250202","article-title":"Cost-effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia","volume":"325","author":"Weeks","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2005.06.001_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0272989X9801800312","article-title":"Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method","volume":"18","author":"Hunink","year":"1998","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jpeds.2005.06.001_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hec.903","article-title":"Cost-effectiveness acceptability curves: facts, fallacies and frequently asked questions","volume":"13","author":"Fenwick","year":"2004","journal-title":"Health Econ"},{"key":"10.1016\/j.jpeds.2005.06.001_bib26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hec.635","article-title":"Representing uncertainty: the role of cost-effectiveness acceptability curves","volume":"10","author":"Fenwick","year":"2001","journal-title":"Health Econ"},{"key":"10.1016\/j.jpeds.2005.06.001_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3476(00)70102-8","article-title":"Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis","volume":"136","author":"Panepinto","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2005.06.001_bib28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-3476(05)83375-X","article-title":"Neonatal screening for sickle-cell disease: a cost-effectiveness analysis","volume":"118","author":"Tsevat","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2005.06.001_bib29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1067\/mpd.2002.128116","article-title":"Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel","volume":"141","author":"Insinga","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2005.06.001_bib30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1542\/peds.110.4.781","article-title":"Cost-benefit analysis of universal tandem mass spectrometry for newborn screening","volume":"110","author":"Schoen","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2005.06.001_bib31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1542\/peds.112.5.1005","article-title":"Newborn screening by tandem mass spectrometry for medium-chain acyl-CoA dehydrogenase deficiency: a cost effectiveness analysis","volume":"112","author":"Venditti","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2005.06.001_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jama.1994.03520100035030","article-title":"Screening for prostate cancer. A decision analytic view","volume":"272","author":"Krahn","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2005.06.001_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-126-5-199703010-00001","article-title":"Cost-effectiveness of screening for carotid stenosis in asymptomatic persons","volume":"126","author":"Lee","year":"1997","journal-title":"Ann Int Med"},{"key":"10.1016\/j.jpeds.2005.06.001_bib34","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1542\/peds.2004-0583","article-title":"Newborn screening for lysosomal storage disorders: Clinical evaluation of a two-tier strategy","volume":"114","author":"Meikle","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2005.06.001_bib35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1542\/peds.99.6.819","article-title":"Newborn screening for cystic fibrosis in Wisconsin: Comparison of biochemical and molecular methods","volume":"99","author":"Gregg","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2005.06.001_bib36","first-page":"1007","article-title":"Relation of cord blood thyroxine and thyrotropin levels to gestational age and birth weight","volume":"123","author":"Prato","year":"1980","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jpeds.2005.06.001_bib37","first-page":"872","article-title":"Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients","volume":"99","author":"M\u00fcller","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2005.06.001_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2004.10.012","article-title":"Development of population-based newborn screening for severe combined immunodeficiency","volume":"115","author":"Chan","year":"2005","journal-title":"J Allergy Clin Immunol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347605004920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347605004920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T01:54:12Z","timestamp":1548035652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347605004920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0022347605004920"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2005.06.001","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}